Sign in

CIK 0001894562 · <br>Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy 10% owner bought 1,500,000 shares at $3.30 ($4,950,000)
  4. 4 Open-market buy Director bought 3,030,300 shares at $3.30 ($9,999,990)
  5. 4 Open-market buy 10% owner bought 3,030,300 shares at $3.30 ($9,999,990)
  6. 4 Open-market buy 10% owner bought 3,030,300 shares at $3.30 ($9,999,990)
  7. 4 Open-market buy 10% owner bought 21,000 shares at $2.52 ($52,830)
  8. 4 Open-market buy 10% owner bought 21,000 shares at $2.16 ($45,402)
  9. 4 Open-market buy 10% owner bought 21,000 shares at $1.49 ($31,196)
  10. 4 Open-market buy 10% owner bought 21,000 shares at $1.60 ($33,590)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chief Business Officer bought 20,000 shares at $1.19 ($23,790)
  19. 4 Open-market buy Chief Technical Officer bought 100,000 shares at $1.13 ($113,000)
  20. 4 Open-market buy Chief Executive Officer bought 125,000 shares at $1.18 ($147,150)

Page 2 of 7 · 140 filings